Today’s networking sessions cover a range of techniques and topics. We have two afternoon networking sessions, from 2:00 to 3:30 pm, to recommend. One addresses the impact of automation and AI in the pharmaceutical R&D laboratory (room 202A). The other offers a forum to address the exchange of safety information concerning extractables and leachables (room 203A).
Advertisement
The session on extractables and leachables will be hosted by James Vergis of the Enabling Technologies Consortium and Lee Nagao of Faegre Drinker Biddle and Reath, LLP. This forum will bring together analytical technology providers and industry members to discuss the current extractables and leachables landscape and collaboration opportunities. Topics to be discussed including the current and upcoming regulatory guidance, data sharing, and leachables risk management.
The forum on automation and AI in the pharmaceutical industry will be hosted by Michael Wleklinski of Merck. The group will address how automation and new developments in artificial intelligence can efficiently impact drug candidate progression by using experimental data. Part of this session will also address adopting artificial intelligence technologies into the laboratory, and what challenges and successes attendees have had in doing so.
